Completed PHASE4 INTERVENTIONAL 2-arm NCT02016443

Tizanidine and Pain After Herniorrhaphy

Investigation of the Effectiveness of Tizanidine on Pain After Herniorrhaphy

Sponsor: Diskapi Teaching and Research Hospital

Updated 6 times since 2017 Last updated: Apr 21, 2015 Started: Nov 30, 2013 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02016443, this PHASE4 trial focuses on Unilateral Inguinal Hernia and remains completed. Sponsored by Diskapi Teaching and Research Hospital, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diskapi Teaching and Research Hospital

Data source: Diskapi Teaching and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)